Appraisal of 5-year recurrence-free survival after surgery in pancreatic ductal adenocarcinoma.
So Jeong YoonSang Hyun ShinSo Kyung YoonJi Hye JungYunghun YouIn Woong HanDong Wook ChoiJin Seok HeoPublished in: Journal of hepato-biliary-pancreatic sciences (2020)
Most prognosticators failed to predict the risk of recurrence in the 5 years following surgery for PDAC, and recurrence can occur even at time points up to 100 months. Therefore, cure of PDAC cannot be guaranteed by a 5-year recurrence-free interval, and further studies into the inherent nature of PDAC are needed to develop adequate surveillance systems which may lead to improvements in survival.